Moreover, it would be useful to further investigate and catalogue the activating mechanisms of MET (such as activating mutations, transcriptional and protein overexpression), and their role in oncogenic signalling in the context of multiple receptor co-activation in lung cancer. Here, MET is linked to lung carcinoma.